AGER and Insulin resistance: Pathway enrichment analysis further indicated the potential involvement of several disease-overlapping pathways, including insulin resistance, neuroactive ligand-receptor interaction, efferocytosis, advanced glycation end product-receptor for advanced glycation end product (AGE-RAGE) signaling, phospholipase D signaling, and renin secretion.